1. [Engineering of a System for the Production of Mutant Human Alpha-Fetoprotein in the Methylotrophic Yeast Pichia pastoris].
- Author
-
Morozkina EV, Vavilova EA, Zatsepin SS, Klyachko EV, Yagudin TA, Chulkin AM, Dudich IV, Semenkova LN, Churilova IV, and Benevolenskii SV
- Subjects
- Cell Line, Tumor, Fermentation, Humans, Mutant Proteins administration & dosage, Mutant Proteins genetics, Pichia genetics, Recombinant Proteins administration & dosage, Recombinant Proteins genetics, Recombinant Proteins isolation & purification, Saccharomyces cerevisiae genetics, alpha-Fetoproteins administration & dosage, alpha-Fetoproteins genetics, alpha-Fetoproteins isolation & purification, Mutant Proteins biosynthesis, Neoplasms drug therapy, Recombinant Proteins biosynthesis, alpha-Fetoproteins biosynthesis
- Abstract
A system for the production of mutant recombinant human alpha-fetoprotein (rhAFPO) lacking the glycosylation site has been engineered in the yeast Pichia pastoris. A strain of the methylotrophic yeast Pichia pastoris GS 115/pPICZ?A/rhAFP0, which produces unglycosylated rhAFPO and secretes it to the culture medium, has been constructed. Optimization and scale-up of the fermentation technology have resulted in an increase in the rhAFP0 yield to 20 mg/L. A scheme of isolation and purification of biologically active rhAFP0 has been developed. The synthesized protein has the antitumor activity, which is analogous to the activity of natural human embryonic alpha-fetoprotein.
- Published
- 2016